Michael Mosley’s son follows in his footsteps by writing book on weight-loss drugs
Michael Mosley’s son follows in his footsteps by writing book on weight-loss drugs - The late TV doctor’s family are ...
MarketBeat on MSN39m
Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Novo Nordisk A/S (NYSE: NVO) has declared that its GLP-1 drugs for chronic obesity, under the brands Ozempic and Wegovy, are ...
Novo Nordisk shares fall on weight-loss drug trial
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.